These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10378086)

  • 1. Molecular properties of inositol 1,4,5-trisphosphate receptors.
    Patel S; Joseph SK; Thomas AP
    Cell Calcium; 1999 Mar; 25(3):247-64. PubMed ID: 10378086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular and functional diversity of inositol triphosphate-induced Ca(2+) release].
    De Smedt H; Parys JB
    Verh K Acad Geneeskd Belg; 1995; 57(5):423-58. PubMed ID: 8571671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IP3 receptor].
    Mikoshiba K; Furuichi T; Michikawa T; Yamamoto-Hino M; Hirashima C; Mizuno H; Inoue T; Uchiyama T
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1596-602. PubMed ID: 9788158
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure and function of inositol 1,4,5-trisphosphate receptor.
    Yoshida Y; Imai S
    Jpn J Pharmacol; 1997 Jun; 74(2):125-37. PubMed ID: 9243320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ and calmodulin differentially modulate myo-inositol 1,4, 5-trisphosphate (IP3)-binding to the recombinant ligand-binding domains of the various IP3 receptor isoforms.
    Vanlingen S; Sipma H; De Smet P; Callewaert G; Missiaen L; De Smedt H; Parys JB
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):275-80. PubMed ID: 10677344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for calmodulin: Ca2+-independent inhibition of type-1 inositol trisphosphate receptors.
    Cardy TJ; Taylor CW
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):447-55. PubMed ID: 9716504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A inhibits inositol 1,4,5-trisphosphate binding to its receptors and release of calcium from intracellular stores in peritoneal macrophages.
    Misra UK; Gawdi G; Pizzo SV
    J Immunol; 1998 Dec; 161(11):6122-7. PubMed ID: 9834096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of inositol trisphosphate receptors.
    Bultynck G; Sienaert I; Parys JB; Callewaert G; De Smedt H; Boens N; Dehaen W; Missiaen L
    Pflugers Arch; 2003 Mar; 445(6):629-42. PubMed ID: 12632182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes.
    Miyakawa T; Maeda A; Yamazawa T; Hirose K; Kurosaki T; Iino M
    EMBO J; 1999 Mar; 18(5):1303-8. PubMed ID: 10064596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2+-calmodulin inhibits Ca2+ release mediated by type-1, -2 and -3 inositol trisphosphate receptors.
    Adkins CE; Morris SA; De Smedt H; Sienaert I; Török K; Taylor CW
    Biochem J; 2000 Jan; 345 Pt 2(Pt 2):357-63. PubMed ID: 10620513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inositol 1,4,5-trisphosphate receptor (IP3 receptor)].
    Mikoshiba K
    Tanpakushitsu Kakusan Koso; 1997 Feb; 42(3 Suppl):224-9. PubMed ID: 9162955
    [No Abstract]   [Full Text] [Related]  

  • 12. The inositol 1,4,5-triphosphate receptor expression in Drosophila suggests a role for IP3 signalling in muscle development and adult chemosensory functions.
    Raghu P; Hasan G
    Dev Biol; 1995 Oct; 171(2):564-77. PubMed ID: 7556937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mini-dystrophin expression down-regulates overactivation of G protein-mediated IP3 signaling pathway in dystrophin-deficient muscle cells.
    Balghi H; Sebille S; Constantin B; Patri S; Thoreau V; Mondin L; Mok E; Kitzis A; Raymond G; Cognard C
    J Gen Physiol; 2006 Feb; 127(2):171-82. PubMed ID: 16446505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium regulation of inositol 1,4,5-trisphosphate receptors.
    Joseph SK; Brownell S; Khan MT
    Cell Calcium; 2005 Dec; 38(6):539-46. PubMed ID: 16198415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
    Singleton PA; Bourguignon LY
    Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation.
    Singleton PA; Bourguignon LY
    Exp Cell Res; 2004 Apr; 295(1):102-18. PubMed ID: 15051494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the gaps in 3D structure of the inositol 1,4,5-trisphosphate receptor-binding core.
    Veresov VG; Konev SV
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1277-85. PubMed ID: 16469298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of and chromogranin effect on inositol 1,4,5-trisphosphate sensitivity of cytoplasmic and nucleoplasmic inositol 1,4,5-trisphosphate receptor/Ca2+ channels.
    Huh YH; Kim KD; Yoo SH
    Biochemistry; 2007 Dec; 46(49):14032-43. PubMed ID: 17997581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postsynaptic IP3 receptor-mediated Ca2+ release modulates synaptic transmission in hippocampal neurons.
    Kelly PT; Mackinnon RL; Dietz RV; Maher BJ; Wang J
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):232-48. PubMed ID: 15857686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation.
    Cárdenas C; Liberona JL; Molgó J; Colasante C; Mignery GA; Jaimovich E
    J Cell Sci; 2005 Jul; 118(Pt 14):3131-40. PubMed ID: 16014380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.